Therapeutic potential of cannabinoids in the management of Alzheimer's Disease and other neurodegenerative conditions
Date
Authors
Major Professor
Advisor
Committee Member
Journal Title
Journal ISSN
Volume Title
Publisher
Authors
Research Projects
Organizational Units
Journal Issue
Is Version Of
Versions
Series
Department
Abstract
Abstract
Alzheimer’s disease (AD) is the most pervasive form of neurodegenerative dementia affecting the global population today. Efforts to develop pharmacological intervention to halt or reverse the progression of AD have proven unsuccessful, resulting in insufficient treatment options for patients with AD which possess limited therapeutic benefits such as symptom management and slowing the inevitable progression of the disease. The lack of effective medications to treat AD has led to an urgent effort to fill this therapeutic gap, prompting researchers to further investigate the proposed anti-inflammatory and neuroprotective properties of cannabinoids in neurological diseases. This paper will review the current literature related to cannabinoids as potential therapeutic agents in the context of neurodegenerative disease.